Vertebral Compression Fracture Devices Market Size, Volume and Revenue Forecast to 2026

The micro-breaks in the building blocks of vertebra mainly caused by bone-thinning are termed as vertebral compression fractures (VCFs). Vertebral compression fracture occurs due to compression of a single bone due to trauma. The surgical approach for VCF treatment comprises injecting bone cement through a small hole in the fractured vertebra to provide immediate pain relief and stabilization to the patient. The cementing material provides a scaffold for the spine bone for added support. Thinning of corticles, reduction in bone mineral density, and osteoporosis are the major factors causing vertebral compression fractures. Postmenopausal women are more prone to vertebral fractures. The ultimate goal of the vertebral compression fracture devices is to eliminate back pain, fuse and repair fractures, restore posture, and provide ease of movement.

Ask for Sample Copy of Research Report At https://www.coherentmarketinsights.com/insight/request-sample/802

Rising prevalence of osteoporosis drives the vertebral compression fracture devices market

According to the International Osteoporosis Foundation estimates in 2010, osteoporosis affects 200 million people globally with approximate 9 million new osteoporotic fractures, with 1.6 million hip fractures, 1.7 million forearm fractures, and 1.4 million clinical vertebral fractures. The rising incidence of arthritis and osteoporosis, inability of medicinal therapy to cure vertebral compression fracture to the optimum level, and the advent of minimally invasive spine surgeries drives the growth of vertebral compression fracture devices market. Moreover, short recovery period, low risk of infection, limited hospital stay, and rise in geriatric population are projected to boost the demand for VCF devices globally. However, stringent regulatory approval process and the risk of post-surgical complications such as neurological injury and compromised pulmonary function are expected to restrain the market growth.

Asia Pacific is projected to grow rapidly with the rise in healthcare expenditures to cater the unmet medical needs

Regional segmentation of the global VCF market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. According to the World Health Organization estimates in 2015, vertebral compression fractures (VCF) are the common type of fragility fractures with 700,000 VCF cases per year in the U.S., with 30% postmenopausal women likely to experience humerus, hip, and spine fractures, thereby propelling the demand for innovative VCF devices. North America is expected to dominate the global market, owing to the surge in procedure volumes, rising prevalence of impairments, spinal disorders such as spinal stenosis, well-defined reimbursement policies, supportive economic base, and high awareness of VCF conditions and treatments available.

Delivering high quality minimally invasive products is expected to push the manufacturing envelope

Key players operating in the global vertebral compression fracture devices market include Alphatec Holdings, Inc., Depuy Synthes, Osseon LLC, VEXIM SA, and Orthovita, Inc. The launch of innovative CurvePlus device and InterV line offers atraumatic treatment allowing pain management clinics to have a safer and quicker procedure. Other key vendors include Stryker Corporation, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., DFine, Inc. and CareFusion Corporation.

Balloon kyphoplasty devices segment is expected to procure largest revenue owing to its beneficial effects

The global vertebral compression fracture devices market is segmented on the basis of technology, diagnosis, surgery, end user, and geography.

On the basis of technology, the global vertebral compression fracture devices market is segmented into:

• Balloon Kyphoplasty Devices
• Vertebroplasty Devices

On the basis of diagnosis, the global vertebral compression fracture devices market is segmented into:

• X-rays, CT scan or MRI
• Radio Scan

On the basis of surgery, the global vertebral compression fracture devices market is segmented into:

• Open Spine Surgery
• Minimally Invasive Spine Surgery
• Lumbar Fusion

Browse Complete Research Report At https://www.coherentmarketinsights.com/ongoing-insight/vertebral-compression-fracture-devices-market-802

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Clinical Data Management Market Share And Future Growth To 2026

The process of collection, documentation, and data storage, which are critical for clinical trials or procedures and to biotechnology companies and pharmaceutical manufacturers is termed as Clinical Data Management (CDM). Clinical data management tool is employed in clinical research for managing the data of a clinical trial. Data management is a process of collection, integration, and management of subject data in compliance with regulatory standards. Clinical data management is a fundamental phase in clinical research leading to the generation of high-quality, reliable, and statistically comprehensive data to reduce time duration from drug development to marketing. The clinical data is captured in a paper or electronic data capture format. Pharma companies, contract research organizations, and IT companies are involved in CDM activities. Data is collected from multiple sources and stored in a patient-centric fashion in a data repository commonly known as clinical data repository.

Get In-Depth Sample Copy of This Research @ https://www.coherentmarketinsights.com/insight/request-sample/795

Rising number of clinical trials drives the clinical data management market

Advantages of web-based data collection tools such as reduced time and ease in data entry, low cost, flexibility in format, and the ability to capture additional response-set information drive the clinical data management market. Additionally, high levels of productivity and efficiency offered by clinical data management are expected to redefine the traditional data management process by the companies thereby augmenting the clinical data management market growth. Also, increase in research and development expenditure of clinical research and life science industries coupled with increasing number of clinical trials is a factor contributing to the growth of clinical data management market.

North America is expected to dominate the market due to rise in demand for patient data standardization

Regional segmentation of clinical data management market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. According to the National Institutes of Health estimates in 2015, around 89,528 clinical trials were conducted in the U.S., which, in turn, raised the demand for storing comprehensive statistical patient data in. Moreover, the growth of North America market is driven by increasing need for data standardization and rising investments by biotechnology and pharmaceutical companies in research and development. The surging growth in Asia Pacific is attributed to a number of factors including rise in outsourcing of clinical trials, availability of diverse patient population, and less regulatory guidelines by the government.

Top Key Players

Key players operating the clinical data management market include OmniComm Systems, Oracle Corporation, BioClinicia, ERT, PHT Corporation, MedNet Solutions Inc., PAREXEL International Corporation, eClinical Solutions Inc., Datatrak International Inc., and Medidata Solutions, Inc.

Focus on high-quality clinical data by Oracle Clinical segment fuels the market growth

The global clinical data management market is segmented on the basis of tools, service, delivery mode, end-use industry, and geography.

On the basis of tools, the global clinical data management market is segmented into:

• Oracle Clinical
• Clintrial
• Macro
• Rave
• eClinical Suite

On the basis of services, the global clinical data management market is segmented into:

• Case Report Form (CRF) Designing
• Data Entry and Validation
• Discrepancy Management
• Medical Coding
• Others

For More Information, Browse Full Report Here: https://www.coherentmarketinsights.com/ongoing-insight/clinical-data-management-market-795

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Myelodysplastic Syndrome Treatment Market Growing at Steady CAGR to 2025

Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature blood cells called as blasts, get stored in the bone marrow and blood and obstruct the natural function of the hematological system which results in depletion of healthy red blood cells, platelets, and white blood cells. Myelodysplastic syndrome is usually seen in geriatric population and more often in older men than women. This syndrome is characterized by certain chromosomal mutations in Janus Kinase gene which include deletion of q arm in one or more chromosomes and complete deletion of chromosome 5 or 7 and an extra copy of chromosome 8. There are various types of myelodysplastic syndrome such as refractory cytopenia with unilineage dysplasia and refractory anemia with ringed sideroblasts among others. Approved drugs for MDS include Vidaza (Azacitidine), Revlimid (Lenalidomide), Decitabine (Dacogen), and Deferasirox (Jadenu). Revlimid (Lenalidomide) patent for MDS indication will be expiring in 2023. A number of generic azacitidine-based products for MDS are launched in the global market.

Get In-Depth Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/775

Rising implications associated with myelodysplastic syndrome are expected to affect the myelodysplastic syndrome treatment market

According to the American Cancer Society, the incidence rate for myelodysplastic syndrome is 13,000 new cases each year which happens at a rate of 4.8 cases per 100,000 people. This trend is heavily affected or rather influenced by the average age of the population which, according to the World Health Organization (WHO), is increasing and is expected to double from 12% to 22% between 2015 and 2050. Furthermore, according to the American Society of Clinical Oncology (ASCO), age plays an important role in the occurrence of myelodysplastic syndrome as most of the people diagnosed with the disease are of age 65 and older. These factors are expected to boost the myelodysplastic syndrome treatment.

The global myelodysplastic syndrome treatment market was valued at US$ 2,213.2 million in 2017 and is expected to witness a CAGR of 12.7% during the forecast period (2017 – 2025).

Endeavor to introduce highly effective therapies for various MDS types would support the market growth

Major pharmaceutical organizations such as Celgene are investing major amounts in research and development of MDS specific drugs and many of their drugs are showing potential in the clinical trials as shown in the table no.1. Furthermore, in 2016, Opsona Therapeutics Ltd. received orphan drug designation for its OPN-305 humanized IgG4 monoclonal antibody for MDS treatment. Also, after Celgene lost its U.S. exclusivity for Vidaza, many generic formulations have entered in the market for Vidaza and Natco Pharma is also expected to launch generic version of Vidaza in 2017, which will further boost myelodysplastic syndrome treatment market.

Global Key Players

Key players operating in the myelodysplastic syndrome treatment market include Celgene, Novartis, and Otsuka. Some of the other market players are Astellas, Astex, Acceleron Pharma, Onconova Pharmaceuticals, GlaxoSmithKline, Eli-Lilly, and CTI Biopharma.

Detailed Segmentation:

Global Myelodysplastic syndrome treatment market, By Drug:

• Azacitidine
• Lenalidomide
• Decitabine
• Deferasirox

Global Myelodysplastic syndrome treatment market, By Geography:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/market-insight/myelodysplastic-syndrome-treatment-market-775

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Computer Aided Detection Market: The Evolution of Future Healthcare Industry

Computer Aided Detection (CAD) software is a set of algorithms that uses pattern recognition method assisting physicians with interpretation of medical images. Increasing number of patients opting for diagnostic imaging techniques is expected to propel the volume of image data to be analyzed. It is a diagnostic analysis technology, which assists physicians in reducing detection errors. CAD software is helpful in diagnosis of several diseases, such as cancer, coronary artery disease, cardiovascular diseases, and neurological diseases through imaging modalities, such as X-Rays imaging, Magnetic Resonance Imaging ultrasound imaging, and computed tomography. It helps in accurate detection of chronic diseases in early stages, reducing mortality rates due to cancer, cardiovascular, and neurological diseases.

Get In-Depth Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/761

Increase in prevalence of the chronic diseases is anticipated to fuel the demand of Computer Aided Detection Market

Increasing cancer treatment awareness and routine medical check-up is driving the demand for CAD market. Advanced digital imaging techniques have enhanced the effectiveness and efficiencies of CAD solutions. Easy integration with various imaging equipment is helping with early detection of chronic diseases. It has applications in clinical and research and development activities. Medical tourism is also boosting the adoption of CAD. Gradual increase in demand for Health Insurance, which requires pre-screening of chronic diseases is driving the growth of CAD market. Major investments in R&D of Computer Aided Detection with 3D imaging are providing opportunities for growth of the market. High cost is the challenge for growth of CAD market.

Intense merger and acquisition among the emerging players to boost the computer aided detection market

Key players involved in global computer aided detection market are GE Healthcare, Philips Healthcare, Hologic,Inc., Inc. iCAD, Agfa-Gevaert N.V., EDDA Technology, Fujifilm Medical System, Invivo Corporation, Hitachi Medical Corporation, and Siemens Healthineers. GE Healthcare got FDA clearance for its Senographe Pristina Dueta, which is claimed to be the 1st patient-assisted mammography device that allows women to control their own compression during the examination. GE healthcare has transform the mammography for reducing the pain during examination. Philips Healthcare has entered an agreement with Belgium-headquartered IBA (ION Beam Applications SA) for providing proton therapy solutions, it is an advanced therapy for treatment of cancer in India.

Computer Aided Detection Market - Taxonomy

Computer Aided Detection Market is segmented on the basis of application, end users, imaging modalities

On the basis of application, the global computer aided detection in healthcare market can be segmented as.

• Lung cancer
• Breast cancer
• Liver cancer
• Bone cancer
• Prostate cancer
• Colorectal cancer
• Others (Cardiovascular and Neurological Indications etc.)

On the basis of imaging modalities, the global Computer Aided Detection market in healthcare market can be segmented as

• Ultrasound imaging
• Mammography
• Tomosynthesis
• Computed tomography
• Magnetic resonance imaging

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/computer-aided-detection-market-761

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Myasthenia Gravis Treatment Market Major Trends & Development Opportunities until 2027

Myasthenia gravis (MG) is a type of chronic autoimmune neuromuscular disease which causes weakness in skeletal muscles in the arms and legs. Double vision, facial paralysis, difficulty in walking, dropping of eyelids, are symptoms of myasthenia gravis. This disease is diagnosed by tests such as repetitive nerve stimulation test, blood test for antibodies, edrophonium test, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI). Corticosteroids drugs (azathioprine, and cyclosporine) and Acetylcholine esterase inhibitors (Edrophonium, and Pyridostigmine) are used for the treatment of MG.

Get In-Depth Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2625

Myasthenia Gravis Treatment Market - Drivers

Consistent research and development activities are expected to propel growth of the myasthenia gravis treatment market. For instance, in October 2017, Alexion Pharmaceuticals, Inc. received approval from the U.S. Food and Drug Administration for Soliris which contains eculizumab as an active component. This drug is used for treatment of antibody positive generalized myasthenia gravis, and it is also used in treatment of paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS).

Increasing number of clinical trials for treatment of myasthenia gravis are expected to drive the myasthenia gravis treatment market growth. For instance, in December 2017, Novartis AG initiated phase II clinical trial of CFZ533 for treatment of severe myasthenia gravis. The main function of CFZ533 is the modification of immune response by deactivation of white blood cells. Hence, it is expected to help with improvement and management of severe myasthenia gravis.

Myasthenia Gravis Treatment Market - Regional Analysis

On the basis of region, the global myasthenia gravis treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold a dominant position in the myasthenia gravis treatment market over the forecast period. This is owing to increasing incidence and prevalence of myasthenia gravis in the U.S. For instance, in October 2018, according to the National Center for Biotechnology Information (NCBI), incidence of myasthenia gravis was around 5 to 30 cases per million person years and prevalence is around 10 to 20 cases per 100,000 population in U.S.

Myasthenia Gravis Treatment Market - Competitive Analysis

Key players operating in the myasthenia gravis treatment market are Novartis AG, Takeda Pharmaceutical Company Limited, Grifols, S.A., Valeant Pharmaceutical International, Inc. Alexion Pharmaceutical Inc., F. Hoffmann-La Roche AG, CSL Behring, Baxter International, Inc., Shire plc, and Avadel Pharmaceutical, PLC.

Myasthenia Gravis Treatment Market – Taxonomy

By Medications

• Cholinesterase Inhibitors
• Corticosteroids
• Immunosuppressants
• Plasmapheresis
• Intravenous immunoglobulin (IVIg)
• Monoclonal Antibody

By Distribution Channels

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Browse Complete Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/myasthenia-gravis-treatment-market-2625

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Spirometer Market Surge in Demand from Medical Device Industry

Difficulty in breathing is a major problem among people across the world. Spirometer is a common test / device used to diagnose and aid in treatment of certain lung diseases. It measures inhalation and exhalation volume of air in one breath. Spirometer is used to diagnose Chronic Obstructive Pulmonary Disease (COPD) and asthma. It is also used to monitor other lung conditions such as chronic bronchitis, pulmonary fibrosis, and emphysema.

Spirometer Market Drivers

Increasing prevalence of respiratory diseases and disorders is expected to propel growth of the spirometer market. According to The World Health Organization’s (WHO) report 2016, around 235 million people suffer from asthma worldwide annually. COPD is a progressive, life -threatening disease, which causes blockage into the air tubes. Hence increasing number of respiratory disease demands for more spirometers and thus support the global spirometer market growth.

Get In-Depth Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2615

Key players in the market are focused on launching new products, which is expected to boost growth of the spirometer market. For instance, in April 2018, NuvoAir AB launched smart wireless spirometer for home use. It is a small, wireless, and portable device that can be easily connected to smartphones via Bluetooth.

Spirometer Market- Regional Analysis

On the basis of region, the global spirometer market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the spirometer market. This is owing to increasing collaboration activities and high incidences of respiratory diseases and disorders in the region. For instance, in December 2016, Propeller Health collaborated with Medical International Research (MIR). Under this collaboration, Propeller Health incorporated MIR’s clinical spirometer into its digitally-guided respiratory therapy platform to improve management of respiratory conditions such as COPD and asthma.

Spirometer Market- Competitive Analysis

Key players operating in the spirometer market include Care Fusion, Philips Healthcare, Welch Allyn, NuVoAir, Propeller Health, Medical International Research, Cardioline, Sibelmed, Cosmed, Masimo Corporation and Fisher, and Paykel Healthcare Limited.

Spirometer Market – Taxonomy

By Technology:

• Flow Measurement
• Volume Measurement
• Peak Flow Measurement

By Indication:

• Asthma
• COPD
• Chronic Bronchitis
• Pulmonary Fibrosis
• Cystic Fibrosis
• Emphysema

Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/spirometer-market-2615

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Cell Culture Media for Vaccine Market To Receive Overwhelming Hike In Revenues By 2026

Cell culture media consists an appropriate source of energy and compounds, which supports growth of cells and regulate the cell cycle. A typical culture medium is composed of vitamins, inorganic salts, complement of amino acids, glucose, and serum which acts as source of growth factors, hormones, and attachment factors. Furthermore, the medium also helps to maintain pH and osmolality.

Market Dynamics

Increasing prevalence of infectious diseases is a major factor driving the global cell culture media for vaccine market growth. According to the Centers for Disease Control and Prevention (CDC), in August 2017, around 104 laboratory-confirmed influenza-associated pediatric deaths were reported, where 66 cases were associated with influenza A viruses and 38 cases were associated with influenza B viruses in the U.S. Moreover, the government initiatives for increasing awareness among the populace regarding prevention of diseases facilitated by vaccines is expected to boost the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.

Get Sample Copy Of The Cell Culture Media for Vaccine Market Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2608

Increasing prevalence of infectious diseases is expected to propel growth of the global cell culture media for vaccine market

High prevalence of infectious diseases is expected to drive the market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), in 2017, around 9,105 tuberculosis cases and around 42,743 cases of lyme disease were reported in the U.S. Also, according to the study conducted by University of Oxford, 2018, the measles cases are currently high in several European countries, where over 82,500 measles cases were registered in Europe in 2018. The number was thrice as compared in 2017, while 15 times in comparison with 2016.

Increasing investments by government organizations and manufacturers focusing on promoting immunization in North America is expected to bolster the market growth

The increasing investments by government organizations and manufacturers focusing on promoting immunization is expected to drive the cell culture media for vaccine market. For instance, in 2015, the Centers for Medicare & Medicaid Services (CMS), with the Centers for Disease Control and Prevention (CDC) introduced a five-year initiative, Healthy People 2020 to improve immunization as well as to reduce the disparity rates caused majorly due to pneumonia, shingles, and influenza. The organizations worked directly with physicians and provider offices, home health agencies, hospitals, and beneficiaries under the guidance of Health Service Advisory Group (HSAG) to promote their initiative.

Key Players

Major players operating in the global cell culture media for vaccine market include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE.

Detailed Segmentation:

Global Cell Culture Media for Vaccine Market, By Application:

• Human Vaccines
• Animal Vaccines

Global Cell Culture Media for Vaccine Market, By Media Type:

• Bovine Derived
  • Fetal bovine serum (FBS)
  • Newborn Calf Serum (NBCS)
  • Adult Bovine Serum (ABS)
  • Bovine Serum Albumin (BSA)
  • Bovine Calf Serum (BCS)
• Porcine Derived
• Animal free/Serum Free Cell Culture

Browse Research Report @ https://www.coherentmarketinsights.com/market-insight/cell-culture-media-for-vaccine-market-2608

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Philippines Radiotherapy Market Sizing the Market Opportunity

Radiation therapy or radiotherapy is a cancer treatment therapy, which uses high doses of radiations to kill cancer cells and shrink tumors. Several types of radiotherapies such as external beam radiation therapy, internal beam radiation therapy/ brachytherapy, and systemic radiation therapy are available to combat various types of cancers prevalent, globally. External beam radiation therapy is used to treat various types of cancers, including brain tumors, bladder cancer, and bone cancers. Brachytherapy is often used to treat cancers of the head and neck, breast, cervix, prostate, and eye, while systemic radiation therapy is often used to treat certain types of thyroid cancers using radioactive iodine.

Get Sample Copy Of The Philippines Radiotherapy Market Report @ https://www.coherentmarketinsights.com/insight/request-sample/2601

Initiatives by various organizations to increase accessibility to radiotherapy is expected to support the market growth

Increasing initiatives by various government organizations to increase access to radiotherapy among patients suffering from cancer in Philippines is expected to create lucrative environment for the Philippines radiotherapy market growth. For instance, due to high prevalence of cancer in Philippines, the Department of Health (DOH), Philippines, in 2016, decided to strategically establish cancer centers in hospitals to make quality radiation therapy services more accessible to cancer patients, especially those outside Metro Manila.

According to DOH, following hospitals had linear accelerators and other devices installed in the facility; Southern Philippines Medical Center, Cagayan Valley Medical Center, Baguio General Hospital and Medical Center, Bicol Medical Center, Zamboanga City Medical Center, Lung Center of the Philippines, and Vicente Sotto Memorial Medical Center.

Philippines radiotherapy market size was valued at US$ 17.6 Mn in 2018 and is expected to witness a CAGR of 5.8% during the forecast period (2018 – 2026).

Market Opportunity

The prevalence of cancer is very high in Philippines and it was found to be second leading cause of death, according to the Philippines Statistics Authority estimates, in 2016. Furthermore, access to radiotherapy is less in Philippines due to less adoption of devices such as Gamma Knife and CyberKnife.

There is a wide gap between the patient and radiotherapy treatment providers. Hence, key players in the market have opportunity to fill this gap by installing their devices in the region and fulfill these unmet needs.

Market Key Players

Key players operating in the Philippines radiotherapy market include Elekta AB, Accuray Incorporated, Varian Medical Systems, Inc., RaySearch Laboratories AB, Mevion Medical Systems, Inc., Isoray Inc., Nordion Inc., Becton, Dickinson and Company, Ion Beam Applications SA, and Hitachi, Ltd.

Detailed Segmentation:

Philippines Radiotherapy Market, By Application:

• Breast Cancer
• Lung Cancer
• Cervical Cancer
• Prostate Cancer
• Head & Neck Cancer
• Hematologic Cancer
• Others

Philippines Radiotherapy Market, By Product Type :

• External Beam Radiotherapy Device

- Linear Accelerators (LINAC)

- Advanced Radiotherapy Device

- Cobalt-60 Teletherapy System

• Internal Radiotherapy (Brachytherapy) Device
• Systemic Radiotherapy

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/market-insight/philippines-radiotherapy-market-2601

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Neurorehabilitation Devices Market Global Outlook 2018-2026

Neurorehabilitation is a well-elaborated therapist-supervised medical procedure, which aims at recovering a nervous system injury resulting from non-functional to functional nervous system and improving the well-being of a person. World health organization (WHO) survey of 2014, revealed that each year around 15 million people are affected by neurological disorders, from which around 5 million suffer from permanent disability. The report also revealed that, around 2.5 million people are affected with multiple sclerosis and 10 million with Parkinson’s disease, every year, throughout the world. Increase in the prevalence of neurological diseases among the populace, creates a huge need to introduce neurorehab centers and neurorehabilitation devices to ensure simplification of normal-routine life and decrease patients’ dependability on others.

Request a Sample Copy of Neurorehabilitation Devices Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/740

Increase in opportunities and demand for neurorehabilitation devices in the market research industry

Higher incidences of neurological disorders has helped boost the demand for neurorehabilitation devices over the recent years. People’s awareness related to health and the increasing investment in healthcare industry have created a high demand for these devices. According to Centers for Disease Control and Prevention (CDCP) 2015, around 130,000 individuals face fatal strokes every year in the United States. Thus, the increasing need to reduce the incidences of strokes every year, has resulted in the increasing demand for neurorehabilitation devices. Large number of people who are affected by Parkinson’s disease are recorded in regions such as U.S., U.K., Finland, Iceland, and Ireland. These regions extensively employ neurorehabilitation devices, fueling market growth.

Asia pacific region making progressive walk towards neurorehabilitation device market

According to world health organization (WHO) 2016, the North American region was leading the global market for using and forming novel neurorehabilitation devices as this region comprises of a large population suffering from neural diseases. The same reports suggests that North America and Europe together hold around 34% of the share in this global market. However, Asia Pacific is expected to progress towards the leading position in the global market for neurorehabilitation devices over the forecast period. . Moreover, Asia Pacific market is increasing the public awareness and investment in health care.

Collaboration of key players to make lucrative developments

The major key players of neurorehabilitation devices market are Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, Tyromotion, Agiliad, Bioxtreme Robotics Rehabilitation, St Jude Medical Inc., Alter G Inc., Denecor, Ekso Bionics Holding Inc., Helius, Interactive Motion Technologies, Kinestica, Kinetic Muscles, Medtronic Plc., and Neurostyle.

The neurorehabilitation devices market has been segmented on the basis of products, indication, and geography:

On the basis of products, the neurorehabilitation devices market is segmented into:

• Wearable Devices
• Brain computer Interface
• Neurorobotic System
• Non-invasive Stimulators

On the basis of indication, the neurorehabilitation devices market is segmented into:

• Parkinson’s Disease
• Stroke
• Traumatic Brain Injury
• Cerebral Palsy

On the basis of region, the neurorehabilitation devices market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/neurorehabilitation-devices-market-740

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Melanoma Treatment Market Perspective with Study of Leading Players 2018 – 2026

Melanoma is a type of skin cancer that develops from the pigment cells known as melanocytes. It is caused due to high exposure to ultraviolet rays, which leads to sunburn, especially at high altitudes. Melanoma is categorized into three: cutaneous, mucosal, and ocular. Cutaneous affects the skin, mucosal affects the mucous membrane in the mouth and nasal passage, and ocular affects the eye. However, early detection of melanoma helps in the treatment and increase survival rates. According to the American Academy of Dermatology 2015 report, the prevalence of melanoma is increasing and spreads to other body parts as well. As it spreads to other body parts, its treatment becomes much more complex. The rare genetic conditions such as xeroderma pigmentosum also increase the risk of melanoma and it is diagnosed with the biopsy of any skin lesion.

Ask for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/719

Development of new drugs fuels the melanoma treatment market

Several drugs in the market have already received FDA approval for melanoma treatment and some are under development. Drugs such as seviprotimut-L by Polynoma’s, talimogene laherparepvec (T-VEC) by Amgen Inc., and zelboraf, by Roche and Genetech together for the treatment of cutaneous melanoma are under development. Selumetinib is under development by AstraZeneca for the treatment of ocular melanoma. In 2011, Yervoy, a monoclonal antibody drug was developed by Bristol-Myers Squibb for the treatment of melanoma and it is the first drug to receive FDA approval. Immunotherapy drugs include opdivo and keytruda, which got FDA approval and created new opportunities in melanoma treatment market. When chemotherapy fails to deliver results, targeted therapy is used, which include BRAF inhibitors. Targeted therapy has limited side effects in comparison with chemotherapy.

Developed regions support the growth of melanoma treatment market

Melanoma treatment market, based on geography, is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the melanoma treatment market due to the high prevalence of melanoma in the region along with well-developed healthcare facilities and increased research and development on melanoma drugs. Moreover, reimbursement policy and increase in per capita income are expected to fuel the melanoma treatment market. Europe is the second largest market and is expected to grow significantly in near future due to increase in melanoma cases and development of novel therapies. Asia Pacific is expected to exhibit moderate growth due to fewer cases of skin cancer, lack of awareness, and high cost of melanoma drugs.

Key Players in the Global Melanoma Treatment Market

Some of the key players identified across the value chain of global melanoma treatment market are Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Genetech Inc., Novartis AG, Polynoma LLC, AstraZeneca, Amgen Inc., Sanofi, Merck & Co. Inc., and Takeda Pharmaceutical Company.

Melanoma Treatment Market Taxonomy:

The global melanoma treatment market is segmented as follows;

By Melanoma Type;

• Cutaneous Melanoma
• Mucosal Melanoma
• Ocular Melanoma

By Therapy;

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Surgical Treatment
• Pharmacological Treatment

Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/melanoma-treatment-market-719

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com